


Agro Chemicals | Small Cap
Astec Lifesciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strengths in solvency, driven by a manageable debt-to-equity ratio and reasonable interest coverage. However, it faces challenges in efficiency, particularly in inventory and receivables management. Growth metrics reveal a decline in revenue and operating profit, alongside a concerning trend in earnings per share. While asset growth remains strong, profitability is under pressure due to shrinking margins and returns. The financial ratios show strengths in book value per share and capital expenditure management, but weaknesses in adjusted earnings and dividend payouts. Overall, Astec Lifesciences exhibits financial resilience but needs to address declining profitability and efficiency to ensure sustainable growth.
Astec Lifesciences, operating in the Chemical & Petrochemicals sector, shows a mixed financial performance. The company demonstrates strengths in solvency, driven by a manageable debt-to-equity ratio and reasonable interest coverage. However, it faces challenges in efficiency, particularly in inventory and receivables management. Growth metrics reveal a decline in revenue and operating profit, alongside a concerning trend in earnings per share. While asset growth remains strong, profitability is under pressure due to shrinking margins and returns. The financial ratios show strengths in book value per share and capital expenditure management, but weaknesses in adjusted earnings and dividend payouts. Overall, Astec Lifesciences exhibits financial resilience but needs to address declining profitability and efficiency to ensure sustainable growth.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-1.36
Industry Median
26.62
Small Cap Median
24.65
P/E RATIO
-1.15
P/B RATIO
0.37
Industry Median
3.32
Small Cap Median
3.13
P/S RATIO
N/A
Industry Median
1.80
Small Cap Median
1.46
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-2.57
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹69.06 as on Feb 20, 2026.
The growth ratios present a mixed picture. While asset growth is strong, declines in revenue, operating profit, and earnings per share raise concerns about the company's ability to sustain growth. The company needs to address the factors contributing to these declines to ensure future growth prospects. Diversifying revenue streams and exploring new market opportunities could help revitalize growth.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 21.98 | -7.24 | -27.07 | -16.81 | 17.59 |
| Operating Profit Growth Rate | 37.5 | -50 | -107.79 | 1000 | -92.42 |
| Earnings Per Share (EPS) Growth | 38.15 | -71.56 | -283.61 | 187.16 | -39.63 |
| Asset Growth Rate | 32.3 | 9.14 | -0.41 | -9.64 | 6.92 |
| Net Income Growth Rate | 38.46 | -71.11 | -280.77 | 187.23 | -40 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Astec Lifesciences Ltd | 4.06 | -1.15 | Neutral | -5.00 | -36.35 | -81.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT